Veeco Instruments to be Acquired by Axcelis Technologies, Shareholders to Receive 0.3575 Shares per Share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: PRnewswire
- Acquisition Investigation: Former Louisiana Attorney General Charles C. Foti and his law firm are investigating the proposed acquisition of Veeco Instruments by Axcelis Technologies, focusing on whether the offered 0.3575 Axcelis shares per Veeco share adequately reflects the company's value, which may indicate undervaluation.
- Shareholder Rights Concern: KSF is seeking to determine if the process leading to the transaction was fair, as any perceived undervaluation could impact shareholder rights and potentially complicate the acquisition process.
- Legal Consultation Services: KSF offers no-obligation legal consultations, encouraging shareholders to express their views on the transaction via email or phone, which may lead to increased shareholder engagement and scrutiny regarding the deal.
- Market Reaction Anticipation: The investigation into the acquisition proposal may cause fluctuations in Veeco's stock price, prompting investors to monitor subsequent legal developments and their potential impact on the company's valuation.
Analyst Views on ACLS
Wall Street analysts forecast ACLS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACLS is 96.80 USD with a low forecast of 84.00 USD and a high forecast of 110.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
3 Buy
3 Hold
1 Sell
Moderate Buy
Current: 92.990
Low
84.00
Averages
96.80
High
110.00
Current: 92.990
Low
84.00
Averages
96.80
High
110.00
About ACLS
Axcelis Technologies, Inc. provides high-productivity solutions for the semiconductor industry. The Company is focused on developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the critical and enabling steps in the IC manufacturing process. Its ion implantation products include high current ion implant, high energy ion implant and medium current ion implant. The Company's Purion H, Purion Dragon, Purion H200, and GSD/E2 Ovation spot beam, high current systems cover all traditional high current requirements as well as those associated with emerging and future devices. Its Purion XE, EXE, and other Purion high energy systems combine its production-proven RF Linac high energy, spot beam technology with the Purion platform wafer handling system. Its medium current ion implant products include its Purion M Si and SiC medium current systems. It also offers its customers aftermarket service and support.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
